Organigram reports impressive growth for 2018 in advance of adult recreational sales results

Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc., a leading licensed producer of cannabis, is pleased to announce its 2018 fiscal year and fourth quarter results. The Company's fiscal year-end and fourth quarter encompasses operations up to and including August 31, 2018 and as a result, does not include adult-use recreational cannabis revenue.

HEXO Corp reports $6.7 million in gross revenue for the first quarter of new fiscal year

HEXO Corp. (TSX:HEXO) is reporting its financial results for the first quarter of the 2019 fiscal year. Gross revenue for the quarter reached $6.7 million, which includes $5.2 million in sales of adult-use cannabis in the first two weeks following legalization in Canada.

3 Canadian Cannabis Producers To Watch

2018 has proven to be a banner year for the cannabis industry and we expect 2019 to be even more significant. Following Altria’s investment in leading Canadian cannabis producer Altria Group (MO), many investors are trying to invest in what could be the next big acquisition target. 

During the next year, we expect the cannabis industry to see significant consolidation and expect to see more companies like Altria and Constellation Brands (STZ) make investments in the sector.

Aphria Signs Letter of Intent for Exclusive Supply Agreement with Insumos Medicos, S.A. to Supply Medical Cannabis in Paraguay

Aphria Inc. (TSX: APHA and NYSE: APHA) today announced that it has signed a Letter of Intent with Insumos Medicos S.A., a Paraguayan pharmaceutical manufacturing, import and distribution company, to enter into an exclusive supply and distribution agreement to provide medical cannabis in Paraguay.

James E. Wagner Cultivation Receives Building Permit for Continued Large Scale Expansion at Second Facility

James E. Wagner Cultivation Corporation (TSX VENTURE: JWCA), is pleased to announce it has received a main building permit from the City of Kitchener – Building Division for the second phase of the construction of its second facility, which is located at 530 Manitou Drive, Kitchener, Ontario, N2C 1L3.

Aurora Cannabis Announces Market Launch of Softgel Capsules

Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that, further to its October 17, 2018 announcement that it had received a sales license from Health Canada permitting the sale of cannabis softgel capsules, the Company has commenced shipments for both the Canadian medical and adult-use markets. Aurora expects to commence exports to international markets in early 2019.